Clinical Trial Update: Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating peripheral stem cell transplant for high-risk leukemia has been terminated. The update provides the termination status but does not i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Diseases
• Myeloproliferative Disorders

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Status: TERMINATED